117 related articles for article (PubMed ID: 15752776)
1. LARGE2 facilitates the maturation of alpha-dystroglycan more effectively than LARGE.
Fujimura K; Sawaki H; Sakai T; Hiruma T; Nakanishi N; Sato T; Ohkura T; Narimatsu H
Biochem Biophys Res Commun; 2005 Apr; 329(3):1162-71. PubMed ID: 15752776
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the LARGE family of putative glycosyltransferases associated with dystroglycanopathies.
Grewal PK; McLaughlan JM; Moore CJ; Browning CA; Hewitt JE
Glycobiology; 2005 Oct; 15(10):912-23. PubMed ID: 15958417
[TBL] [Abstract][Full Text] [Related]
3. Endogenous glucuronyltransferase activity of LARGE or LARGE2 required for functional modification of α-dystroglycan in cells and tissues.
Inamori K; Willer T; Hara Y; Venzke D; Anderson ME; Clarke NF; Guicheney P; Bönnemann CG; Moore SA; Campbell KP
J Biol Chem; 2014 Oct; 289(41):28138-48. PubMed ID: 25138275
[TBL] [Abstract][Full Text] [Related]
4. Xylosyl- and glucuronyltransferase functions of LARGE in α-dystroglycan modification are conserved in LARGE2.
Inamori K; Hara Y; Willer T; Anderson ME; Zhu Z; Yoshida-Moriguchi T; Campbell KP
Glycobiology; 2013 Mar; 23(3):295-302. PubMed ID: 23125099
[TBL] [Abstract][Full Text] [Related]
5. Wnt-driven LARGE2 mediates laminin-adhesive O-glycosylation in human colonic epithelial cells and colorectal cancer.
Dietinger V; García de Durango CR; Wiechmann S; Boos SL; Michl M; Neumann J; Hermeking H; Kuster B; Jung P
Cell Commun Signal; 2020 Jun; 18(1):102. PubMed ID: 32586342
[TBL] [Abstract][Full Text] [Related]
6. LARGE2 generates the same xylose- and glucuronic acid-containing glycan structures as LARGE.
Ashikov A; Buettner FF; Tiemann B; Gerardy-Schahn R; Bakker H
Glycobiology; 2013 Mar; 23(3):303-9. PubMed ID: 23135544
[TBL] [Abstract][Full Text] [Related]
7. Like-acetylglucosaminyltransferase (LARGE)-dependent modification of dystroglycan at Thr-317/319 is required for laminin binding and arenavirus infection.
Hara Y; Kanagawa M; Kunz S; Yoshida-Moriguchi T; Satz JS; Kobayashi YM; Zhu Z; Burden SJ; Oldstone MB; Campbell KP
Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17426-31. PubMed ID: 21987822
[TBL] [Abstract][Full Text] [Related]
8. Localization and functional analysis of the LARGE family of glycosyltransferases: significance for muscular dystrophy.
Brockington M; Torelli S; Prandini P; Boito C; Dolatshad NF; Longman C; Brown SC; Muntoni F
Hum Mol Genet; 2005 Mar; 14(5):657-65. PubMed ID: 15661757
[TBL] [Abstract][Full Text] [Related]
9. Genes required for functional glycosylation of dystroglycan are conserved in zebrafish.
Moore CJ; Goh HT; Hewitt JE
Genomics; 2008 Sep; 92(3):159-67. PubMed ID: 18632251
[TBL] [Abstract][Full Text] [Related]
10. Intracellular binding of fukutin and alpha-dystroglycan: relation to glycosylation of alpha-dystroglycan.
Yamamoto T; Kawaguchi M; Sakayori N; Muramatsu F; Morikawa S; Kato Y; Shibata N; Kobayashi M
Neurosci Res; 2006 Dec; 56(4):391-9. PubMed ID: 17005282
[TBL] [Abstract][Full Text] [Related]
11. LARGE can functionally bypass alpha-dystroglycan glycosylation defects in distinct congenital muscular dystrophies.
Barresi R; Michele DE; Kanagawa M; Harper HA; Dovico SA; Satz JS; Moore SA; Zhang W; Schachter H; Dumanski JP; Cohn RD; Nishino I; Campbell KP
Nat Med; 2004 Jul; 10(7):696-703. PubMed ID: 15184894
[TBL] [Abstract][Full Text] [Related]
12. Loss of LARGE2 disrupts functional glycosylation of α-dystroglycan in prostate cancer.
Esser AK; Miller MR; Huang Q; Meier MM; Beltran-Valero de Bernabé D; Stipp CS; Campbell KP; Lynch CF; Smith BJ; Cohen MB; Henry MD
J Biol Chem; 2013 Jan; 288(4):2132-42. PubMed ID: 23223448
[TBL] [Abstract][Full Text] [Related]
13. Biochemical correlation of activity of the α-dystroglycan-modifying glycosyltransferase POMGnT1 with mutations in muscle-eye-brain disease.
Voglmeir J; Kaloo S; Laurent N; Meloni MM; Bohlmann L; Wilson IB; Flitsch SL
Biochem J; 2011 Jun; 436(2):447-55. PubMed ID: 21361872
[TBL] [Abstract][Full Text] [Related]
14. LARGE2-dependent glycosylation confers laminin-binding ability on proteoglycans.
Inamori KI; Beedle AM; de Bernabé DB; Wright ME; Campbell KP
Glycobiology; 2016 Dec; 26(12):1284-1296. PubMed ID: 27496765
[TBL] [Abstract][Full Text] [Related]
15. Investigating the functions of LARGE: lessons from mutant mice.
Hewitt JE
Methods Enzymol; 2010; 479():367-86. PubMed ID: 20816177
[TBL] [Abstract][Full Text] [Related]
16. Loss of alpha-dystroglycan laminin binding in epithelium-derived cancers is caused by silencing of LARGE.
de Bernabé DB; Inamori K; Yoshida-Moriguchi T; Weydert CJ; Harper HA; Willer T; Henry MD; Campbell KP
J Biol Chem; 2009 Apr; 284(17):11279-84. PubMed ID: 19244252
[TBL] [Abstract][Full Text] [Related]
17. Transgenic overexpression of LARGE induces α-dystroglycan hyperglycosylation in skeletal and cardiac muscle.
Brockington M; Torelli S; Sharp PS; Liu K; Cirak S; Brown SC; Wells DJ; Muntoni F
PLoS One; 2010 Dec; 5(12):e14434. PubMed ID: 21203384
[TBL] [Abstract][Full Text] [Related]
18. Disruption of perlecan binding and matrix assembly by post-translational or genetic disruption of dystroglycan function.
Kanagawa M; Michele DE; Satz JS; Barresi R; Kusano H; Sasaki T; Timpl R; Henry MD; Campbell KP
FEBS Lett; 2005 Aug; 579(21):4792-6. PubMed ID: 16098969
[TBL] [Abstract][Full Text] [Related]
19. B4GAT1 is the priming enzyme for the LARGE-dependent functional glycosylation of α-dystroglycan.
Praissman JL; Live DH; Wang S; Ramiah A; Chinoy ZS; Boons GJ; Moremen KW; Wells L
Elife; 2014 Oct; 3():. PubMed ID: 25279697
[TBL] [Abstract][Full Text] [Related]
20. Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE.
Inamori K; Yoshida-Moriguchi T; Hara Y; Anderson ME; Yu L; Campbell KP
Science; 2012 Jan; 335(6064):93-6. PubMed ID: 22223806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
